Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fecobionics in Biofeedback Therapy in Dyssynergia Patients
Sponsor: The California Medical Innovations Institute, Inc.
Summary
Constipation affects 12-19% of Americans. Pelvic floor dyssynergia is considered to play an important role in constipation but the underlying mechanisms are not well understood in individual patients. The investigators have developed a novel device named Fecobionics that provide detailed mapping of physiological parameters during defecation. The aim of the study is to use Fecobionics to assess anorectal function in dyssynergia patients and monitor and predict the outcome of the biofeedback therapy.
Official title: Fecobionics to Monitor and Predict Biofeedback Therapy in Dyssynergia Patients
Key Details
Gender
All
Age Range
21 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2023-10-03
Completion Date
2027-03-31
Last Updated
2025-10-21
Healthy Volunteers
No
Conditions
Interventions
Fecobionics
Fecobionics is a novel device to be inserted through the anal canal into rectum for studying defecation. Anorectal manometry and balloon expulsion test may be used as reference. Anorectal manometry and balloon expulsive test are standard methods for anorectal functional measurement.
Locations (2)
California Medical Innovations Institute
San Diego, California, United States
Digestive Health Center- Augusta University
Augusta, Georgia, United States